Literature DB >> 9398802

Serologic assay for secretory component distinguishes mechanical from hepatocellular cholestasis in humans.

M R Versland1, G Y Wu, F S Gorelick, J M Larkin.   

Abstract

In rats, serum secretory component (SC) is elevated in mechanical but not hepatocellular cholestasis. To determine if serum SC might distinguish cholestatic syndromes in humans, serum samples were obtained from control subjects and patients with mechanical and hepatocellular cholestasis. Equal volumes of serum were assayed for SC by immunoblotting with an antibody specific for human SC. Quantitative densitometry of these immunoblots showed that in mechanically obstructed patients serum SC was reversibly elevated to a level approximately 10-fold higher than that of patients with hepatocellular cholestasis (P < 0.001). When comparing the two cholestatic groups, levels of serum alkaline phosphatase, but not bilirubin and alanine aminotransferase, were significantly higher in the group with mechanical cholestasis (P < 0.01). When comparing individual patients, serum SC was more reliable than alkaline phosphatase in distinguishing the two cholestatic syndromes (P < 0.05). Thus, serum SC may distinguish mechanical from hepatocellular cholestasis in humans.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398802     DOI: 10.1023/a:1018810500006

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Effect of obstructive cholestasis on membrane traffic and domain-specific expression of plasma membrane proteins in rat liver parenchymal cells.

Authors:  B Stieger; P J Meier; L Landmann
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

2.  Possible mechanisms of elevation of serum secretory immunoglobulin A in liver diseases.

Authors:  Y Fukuda; H Nagura; J Asai; T Satake
Journal:  Am J Gastroenterol       Date:  1986-05       Impact factor: 10.864

3.  Hepatic immunohistochemical localization of the tight junction protein ZO-1 in rat models of cholestasis.

Authors:  J M Anderson; J L Glade; B R Stevenson; J L Boyer; M S Mooseker
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  No increase of biliary permeability in ethinylestradiol-treated rats.

Authors:  H Jaeschke; H Krell; E Pfaff
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

5.  Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis.

Authors:  J B Burgess; J U Baenziger; W R Brown
Journal:  Hepatology       Date:  1992-04       Impact factor: 17.425

6.  Dual role of the liver in regulating circulating polymeric IgA in man: studies on patients with liver disease.

Authors:  K G Chandy; S G Hübscher; E Elias; J Berg; M Khan; D Burnett
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

Review 7.  Clinical evaluation of jaundice. A guideline of the Patient Care Committee of the American Gastroenterological Association.

Authors:  B B Frank
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

8.  IGA in human bile and liver.

Authors:  H Nagura; P D Smith; P K Nakane; W R Brown
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

9.  Transcytotic vesicular carriers for polymeric IgA receptors accumulate in rat hepatocytes after bile duct ligation.

Authors:  J M Larkin; G E Palade
Journal:  J Cell Sci       Date:  1991-02       Impact factor: 5.285

10.  Biogenesis of the polymeric IgA receptor in rat hepatocytes. II. Localization of its intracellular forms by cell fractionation studies.

Authors:  E S Sztul; K E Howell; G E Palade
Journal:  J Cell Biol       Date:  1985-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.